Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.45 USD | +0.44% | -8.81% | -38.56% |
05-24 | Sector Update: Health Care Stocks Advance Pre-Bell Friday | MT |
05-24 | Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test | MT |
Sales 2024 * | 2.83B 222B | Sales 2025 * | 3.22B 253B | Capitalization | 8.39B 659B |
---|---|---|---|---|---|
Net income 2024 * | -196M -15.39B | Net income 2025 * | -25M -1.96B | EV / Sales 2024 * | 3.52 x |
Net Debt 2024 * | 1.59B 125B | Net Debt 2025 * | 1.18B 92.95B | EV / Sales 2025 * | 2.97 x |
P/E ratio 2024 * |
-43.4
x | P/E ratio 2025 * |
-463
x | Employees | 6,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Exact Sciences Corporation
1 day | +0.44% | ||
1 week | -8.81% | ||
1 month | -24.26% | ||
3 months | -23.54% | ||
6 months | -32.19% | ||
Current year | -38.56% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 17/03/09 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 05/03/18 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/01/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 31/12/14 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 17/03/09 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 21/04/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.80% | 0 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 45.45 | +0.44% | 2,144,952 |
30/05/24 | 45.25 | +0.96% | 2,571,711 |
29/05/24 | 44.82 | -4.68% | 4,726,566 |
28/05/24 | 47.02 | -5.66% | 3,979,641 |
Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.56% | 8.39B | |
+0.18% | 3.32B | |
+9.29% | 2.48B | |
-18.21% | 2.06B | |
-24.57% | 1.59B | |
+32.37% | 1.15B | |
-7.64% | 704M | |
+8.42% | 678M | |
-29.59% | 508M | |
-6.56% | 273M |
- Stock Market
- Equities
- EXAS Stock